Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 3 | 2024 | 64 | 1.690 |
Why?
|
| Inflammation | 4 | 2022 | 626 | 1.030 |
Why?
|
| Neural Pathways | 1 | 2022 | 120 | 0.770 |
Why?
|
| Immunologic Memory | 1 | 2021 | 58 | 0.730 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2022 | 108 | 0.730 |
Why?
|
| Mothers | 1 | 2022 | 121 | 0.720 |
Why?
|
| Schizophrenia | 3 | 2016 | 47 | 0.680 |
Why?
|
| Psychotic Disorders | 2 | 2018 | 22 | 0.580 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 7 | 0.450 |
Why?
|
| Toxoplasmosis | 1 | 2014 | 11 | 0.440 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 66 | 0.430 |
Why?
|
| Cytokines | 2 | 2019 | 445 | 0.410 |
Why?
|
| Neurons | 2 | 2024 | 282 | 0.360 |
Why?
|
| Pregnancy | 3 | 2022 | 1181 | 0.200 |
Why?
|
| Receptors, Dopamine | 1 | 2022 | 3 | 0.200 |
Why?
|
| Neostriatum | 1 | 2022 | 7 | 0.200 |
Why?
|
| Animals | 5 | 2024 | 10399 | 0.190 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 50 | 0.190 |
Why?
|
| Chromatin | 1 | 2022 | 79 | 0.190 |
Why?
|
| Ethanol | 1 | 2021 | 123 | 0.170 |
Why?
|
| Stress, Psychological | 2 | 2024 | 219 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2021 | 225 | 0.160 |
Why?
|
| Poly I-C | 1 | 2019 | 10 | 0.160 |
Why?
|
| Body Temperature Regulation | 1 | 2019 | 12 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2022 | 522 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 47 | 0.150 |
Why?
|
| Mice | 3 | 2024 | 4645 | 0.150 |
Why?
|
| Receptors, GABA | 1 | 2018 | 5 | 0.150 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 131 | 0.150 |
Why?
|
| Corticosterone | 1 | 2018 | 34 | 0.140 |
Why?
|
| Female | 6 | 2022 | 15156 | 0.140 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 80 | 0.140 |
Why?
|
| Antibodies, Protozoan | 1 | 2016 | 8 | 0.130 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2016 | 12 | 0.130 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 9 | 0.130 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 48 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 41 | 0.130 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 92 | 0.130 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 79 | 0.130 |
Why?
|
| Brain | 1 | 2021 | 739 | 0.130 |
Why?
|
| Biomarkers | 2 | 2016 | 755 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 136 | 0.110 |
Why?
|
| Antibodies | 1 | 2014 | 124 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2018 | 663 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 270 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 1570 | 0.090 |
Why?
|
| Male | 5 | 2024 | 13487 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 1461 | 0.090 |
Why?
|
| Young Adult | 2 | 2016 | 2731 | 0.090 |
Why?
|
| Humans | 4 | 2021 | 28121 | 0.080 |
Why?
|
| Adult | 3 | 2016 | 7757 | 0.070 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2024 | 5 | 0.060 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 5 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2024 | 136 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 134 | 0.050 |
Why?
|
| Cognition | 1 | 2024 | 322 | 0.040 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 272 | 0.040 |
Why?
|
| Fetus | 1 | 2019 | 77 | 0.040 |
Why?
|
| Placenta | 1 | 2019 | 75 | 0.040 |
Why?
|
| RNA | 1 | 2019 | 111 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 155 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2024 | 1433 | 0.030 |
Why?
|
| Schizophrenic Psychology | 1 | 2016 | 7 | 0.030 |
Why?
|
| Herpesvirus 2, Human | 1 | 2016 | 4 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2016 | 24 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2016 | 22 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 79 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 98 | 0.030 |
Why?
|
| Toxoplasma | 1 | 2016 | 32 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 243 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 722 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 886 | 0.030 |
Why?
|
| Adolescent | 1 | 2016 | 3123 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 7164 | 0.010 |
Why?
|